This company is included in Intelligence Lab

PathAI

PathAI logo

Website
http://pathai.com/
Founded
2016

Technologies

AI Companies (Drug Discovery)

PathAI's mission is to improve patient outcomes with AI-powered pathology. Our platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine learning.

digital pathology immuno-oncology companion diagnostics precision medicine computational pathology

Articles Mentioning This Company

How Big Pharma Adopts AI To Boost Drug Discovery

How Big Pharma Adopts AI To Boost Drug Discovery

     Articles
(Last updated: October 2025) Since 1950, when Alan Turing introduced the concept of 'thinking machines', artificial intelligence has steadily advanced—from the rise of neural networks in the 1980s to the release of OpenAI’s GPT-3 in 2020, which paved the way for ChatGPT in 2022. Today, AI has become an integral …
9 Companies Using AI to Improve Clinical Trials to Watch in 2023

9 Notable AI Companies in Clinical Research to Watch in 2023

     Articles
The clinical trial is a critical stage of drug development workflow, with an estimated average success rate of about 11% for drug candidates moving from Phase 1 towards approval. Even if the drug candidate is safe and efficacious, clinical trials might fail due to the lack of financing, insufficient enrollment, …